- Home
- AQST vs BRSP Comparison
AQST vs BRSP Comparison
Compare AQST & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | BRSP |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 593.4M |
| IPO Year | 2007 | 2017 |
Fundamental Metrics
Financial Performance| Metric | AQST | BRSP |
|---|---|---|
| Price | $4.67 | $4.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $9.00 | $6.50 |
| AVG Volume (30 Days) | ★ 2.7M | 1.0M |
| Earning Date | 05-01-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.03% |
| EPS Growth | N/A | ★ 75.24 |
| EPS | N/A | ★ N/A |
| Revenue | $67,430,000.00 | ★ $330,587,000.00 |
| Revenue This Year | $10.08 | N/A |
| Revenue Next Year | $49.60 | $17.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.94 | $4.43 |
| 52 Week High | $7.55 | $6.17 |
Technical Indicators
Market Signals| Indicator | AQST | BRSP |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 22.04 |
| Support Level | $4.03 | N/A |
| Resistance Level | $5.10 | $5.75 |
| Average True Range (ATR) | 0.23 | 0.09 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 23.73 | 2.35 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.